ELIAS JOSEPH JABBOUR to Myeloid-Lymphoid Leukemia Protein
This is a "connection" page, showing publications ELIAS JOSEPH JABBOUR has written about Myeloid-Lymphoid Leukemia Protein.
Connection Strength
0.842
-
The early achievement of measurable residual disease negativity in the treatment of adults with Philadelphia-negative B-cell acute lymphoblastic leukemia is a strong predictor for survival. Am J Hematol. 2020 02; 95(2):144-150.
Score: 0.615
-
Predictors of outcomes in adults with acute myeloid leukemia and KMT2A rearrangements. Blood Cancer J. 2021 09 29; 11(9):162.
Score: 0.175
-
Myeloid lineage switch in KMT2A-rearranged acute lymphoblastic leukemia treated with lymphoid lineagedirected therapies. Haematologica. 2024 Jan 01; 109(1):293-297.
Score: 0.051